These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2966799)
1. The binding sites of insulin-like growth factor I (IGF I) to type I IGF receptor and to a monoclonal antibody. Mapping by chemical modification of tyrosine residues. Maly P; Lüthi C J Biol Chem; 1988 May; 263(15):7068-72. PubMed ID: 2966799 [TBL] [Abstract][Full Text] [Related]
2. Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors. Cascieri MA; Chicchi GG; Applebaum J; Green BG; Hayes NS; Bayne ML J Biol Chem; 1989 Feb; 264(4):2199-202. PubMed ID: 2536701 [TBL] [Abstract][Full Text] [Related]
3. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes. Cara JF; Nakagawa SH; Tager HS Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179 [TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor (IGF) binding site of bovine insulin-like growth factor binding protein-2 (bIGFBP-2) probed by iodination. Hobba GD; Forbes BE; Parkinson EJ; Francis GL; Wallace JC J Biol Chem; 1996 Nov; 271(48):30529-36. PubMed ID: 8940022 [TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody to the type 1 insulin-like growth factor and insulin receptors stimulates deoxyribonucleic acid synthesis in human and murine fibroblasts. Cara JF; Stuart CA; Furlanetto RW Endocrinology; 1988 Sep; 123(3):1341-7. PubMed ID: 2969801 [TBL] [Abstract][Full Text] [Related]
6. Identification of the insulin-like growth factor I (IGF I) epitopes recognized by monoclonal and polyclonal antibodies to IGF I. Cascieri MA; Bayne ML; Ber E; Green BG; Men GW; Chicchi GG Endocrinology; 1990 Jun; 126(6):2773-7. PubMed ID: 1693561 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein. An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction. Moss JA; Francis GL; Ross M; Wallace JC; Ballard FJ J Biol Chem; 1991 Jan; 266(2):909-14. PubMed ID: 1702441 [TBL] [Abstract][Full Text] [Related]
8. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. Bayne ML; Applebaum J; Chicchi GG; Miller RE; Cascieri MA J Biol Chem; 1990 Sep; 265(26):15648-52. PubMed ID: 2168421 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of insulin-like growth factor I receptor by insulin receptor tyrosine kinase in intact cultured skeletal muscle cells. Beguinot F; Smith RJ; Kahn CR; Maron R; Moses AC; White MF Biochemistry; 1988 May; 27(9):3222-8. PubMed ID: 2839227 [TBL] [Abstract][Full Text] [Related]
10. Insulin receptor is phosphorylated in response to treatment of HepG2 cells with insulin-like growth factor I. Duronio V Biochem J; 1990 Aug; 270(1):27-32. PubMed ID: 1697749 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites. Casella SJ; Han VK; D'Ercole AJ; Svoboda ME; Van Wyk JJ J Biol Chem; 1986 Jul; 261(20):9268-73. PubMed ID: 3013881 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a subtype of insulin-like growth factor I receptor in brain. Heidenreich KA; Freidenberg GR; Figlewicz DP; Gilmore PR Regul Pept; 1986 Nov; 15(4):301-10. PubMed ID: 2948220 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein. Rutanen EM; Kärkkäinen T; Lundqvist C; Pekonen F; Ritvos O; Tanner P; Welin M; Weber T Biochem Biophys Res Commun; 1988 Apr; 152(1):208-15. PubMed ID: 2451912 [TBL] [Abstract][Full Text] [Related]
14. Specificity of tyrosine protein kinases of the structurally related receptors for insulin and insulin-like growth factor I: Tyr-containing synthetic polymers as specific inhibitors or substrates. Sahal D; Ramachandran J; Fujita-Yamaguchi Y Arch Biochem Biophys; 1988 Jan; 260(1):416-26. PubMed ID: 2893587 [TBL] [Abstract][Full Text] [Related]
15. Functional properties of an isolated alpha beta heterodimeric human placenta insulin-like growth factor 1 receptor complex. Feltz SM; Swanson ML; Wemmie JA; Pessin JE Biochemistry; 1988 May; 27(9):3234-42. PubMed ID: 2968813 [TBL] [Abstract][Full Text] [Related]
16. Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor. Cascieri MA; Chicchi GG; Applebaum J; Hayes NS; Green BG; Bayne ML Biochemistry; 1988 May; 27(9):3229-33. PubMed ID: 2839228 [TBL] [Abstract][Full Text] [Related]
17. Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions. Busby WH; Klapper DG; Clemmons DR J Biol Chem; 1988 Oct; 263(28):14203-10. PubMed ID: 2971653 [TBL] [Abstract][Full Text] [Related]
18. Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors. Wang JF; Hampton B; Mehlman T; Burgess WH; Rechler MM Biochem Biophys Res Commun; 1988 Dec; 157(2):718-26. PubMed ID: 2974285 [TBL] [Abstract][Full Text] [Related]